Loading…
Envista Holdings Corporation is projected to rise to $33.64 by 2027, a +21% move from its current price of $27.78. NVST is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $27.32 | $27.80 | $28.29 | +0.06% |
| Aug 2 | $27.14 | $27.81 | $28.51 | +0.12% |
| Aug 3 | $27.00 | $27.83 | $28.68 | +0.18% |
| Aug 4 | $26.89 | $27.85 | $28.84 | +0.24% |
| Aug 5 | $26.80 | $27.86 | $28.97 | +0.30% |
| Aug 6 | $26.72 | $27.88 | $29.10 | +0.36% |
| Aug 7 | $26.64 | $27.90 | $29.21 | +0.42% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $26.64 | $27.90 | $29.21 | +0.42% |
| Week 2 | $26.25 | $28.02 | $29.90 | +0.85% |
| Week 3 | $25.98 | $28.14 | $30.47 | +1.28% |
| Week 4 | $25.77 | $28.25 | $30.98 | +1.71% |
| Week 5 | $25.60 | $28.37 | $31.46 | +2.14% |
| Week 6 | $25.45 | $28.50 | $31.90 | +2.57% |
| Week 7 | $25.33 | $28.62 | $32.33 | +3.01% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables.
The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands.
The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
Envista Holdings Corporation (NVST) current price is $26.74 with a market cap of $4.35B, and it is ranked 1373 by market size.
The stock sits in the healthcare sector and trades in a market environment where the near-term technical picture aligns with a bullish posture. The price is supported by a 30-day range and a defined resistance level, providing a framework for upside potential in the coming years.
From a price outlook perspective, the forecast spans 2026 through 2050, with multi-year upside highlighted by a rising average price and substantial max values in later years. The latest long-range view points to meaningful appreciation from mid-2020s onward, culminating in very high max levels by 2050.
A major floor 19.4% below — a decisive break under it would weaken the trend.
The nearest floor, 10.5% below — buyers have tended to step in here.
Price is pressing into resistance (2.1% away) — a breakout level to watch.
A major ceiling 9.8% above — clearing it would confirm fresh momentum.
Key NVST support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NVST market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $27.22 | Buy | $27.41 | Buy |
| MA 10 | $26.89 | Buy | $27.07 | Buy |
| MA 20 | $26.73 | Buy | $26.70 | Buy |
| MA 50 | $25.39 | Buy | $26.05 | Buy |
| MA 100 | $25.60 | Buy | $25.54 | Buy |
| MA 200 | $24.29 | Buy | $24.43 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 61.32 | Neutral |
| Stoch RSI (14) | 62.61 | Neutral |
| CCI (20) | 128.15 | Buy |
| Williams %R (14) | -26.11 | Info |
| MACD (12,26,9) | 0.08 | Buy |
| ROC (12) | 6.40 | Buy |
| Bollinger %B (20,2) | 0.88 | Neutral |
| Stochastic %K (14) | 73.89 | Neutral |
| TRIX (15) | 0.23 | Buy |
| Awesome (5,34) | 0.90 | Buy |
| Ultimate (7,14,28) | 62.71 | Neutral |
| Momentum (10) | 0.79 | Buy |
| Aroon Osc (25) | 60.00 | Buy |
| Hull MA (9) | 27.84 | Sell |
| ADX (14) | 16.74 | Neutral |
| ATR (14) | 0.44 | Info |
The near-term technical picture shows a bullish stance.
RSI(14) is 60, indicating room for upside without being overbought. The 50-day simple moving average sits at $24.91 and the 200-day simple moving average at $24.00, signaling a constructive trend.
In the 30-day range, the price has traveled between $23.98 and $29.82, with a support level at $22.87 and a resistance at $27.63. These levels provide a framework for short-term trading and risk management.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $21.69 | $27.78 | $36.05 | 0% | Neutral | |
| $27.58 | $33.64 | $42.87 | +21% | Bullish | |
| $29.27 | $36.38 | $47.63 | +31% | Bullish | |
| $34.35 | $43.36 | $58.00 | +56% | Bullish | |
| $38.92 | $49.79 | $67.81 | +79% | Bullish | |
| $45.28 | $58.64 | $81.14 | +111% | Bullish | |
| $54.90 | $71.90 | $100.90 | +159% | Bullish | |
| $57.36 | $75.92 | $107.93 | +173% | Bullish | |
| $59.05 | $78.93 | $113.56 | +184% | Bullish | |
| $65.12 | $87.88 | $127.84 | +216% | Bullish | |
| $103.12 | $145.14 | $221.30 | +422% | Bullish | |
| $209.11 | $315.70 | $516.03 | +10.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $21.69 | $27.78 | $32.36 | +0.00% |
| August 2026 | $24.66 | $28.76 | $34.17 | +3.52% |
| September 2026 | $25.03 | $29.36 | $35.21 | +2.08% |
| October 2026 | $24.60 | $28.98 | $35.01 | -1.30% |
| November 2026 | $24.48 | $28.95 | $35.19 | -0.11% |
| December 2026 | $24.86 | $29.50 | $36.05 | +1.90% |
Click any year to see its month-by-month NVST forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, NVST is projected to trade between $21.69 and $36.05, averaging $27.78 — a potential gain of 0% from today's $27.78. Price action looks broadly range-bound.
Envista Holdings Corporation's 2027 outlook centres on $33.64, within a $27.58 to $42.87 range. That is up +21% on the projected 2026 average. That marks a +21% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, NVST could reach as high as $47.63, with a base case around $36.38 and support toward $29.27 — roughly +31% from $27.78. Momentum favours further upside here.
Expect NVST to range from $34.35 to $58.00 through 2029. The $43.36 average target implies a +56% move from current prices. That is up +19% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The NVST price prediction for 2030 points to an average of $49.79 (low $38.92, high $67.81) — a potential gain of +79% on today's $27.78. Momentum favours further upside here.
In 2031, NVST is projected to trade between $45.28 and $81.14, averaging $58.64 — a potential gain of +111% from today's $27.78. That is up +18% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Envista Holdings Corporation's 2032 outlook centres on $71.90, within a $54.90 to $100.90 range. That is up +23% on the projected 2031 average. That marks a +159% change versus current levels. Momentum favours further upside here.
By 2033, NVST could reach as high as $107.93, with a base case around $75.92 and support toward $57.36 — roughly +173% from $27.78. Buyers look set to stay in control over this stretch.
Expect NVST to range from $59.05 to $113.56 through 2034. The $78.93 average target implies a +184% move from current prices. That is up +4% on the projected 2033 average. Momentum favours further upside here.
The NVST price prediction for 2035 points to an average of $87.88 (low $65.12, high $127.84) — a potential gain of +216% on today's $27.78. Buyers look set to stay in control over this stretch.
In 2040, NVST is projected to trade between $103.12 and $221.30, averaging $145.14 — a potential gain of +422% from today's $27.78. That is up +65% on the projected 2035 average. Momentum favours further upside here.
Envista Holdings Corporation's 2050 outlook centres on $315.70, within a $209.11 to $516.03 range. That is up +118% on the projected 2040 average. That marks a +10.4x change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in NVST today (≈ 35.99712 NVST) could be worth
$11,364.22
+$10,364.22 (+1036%) by 2050 · US Dollar
Based on the average projected NVST price of $315.7 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NVSTwould be worth at today's price.
$1,000 invested in NVST on Jul 30, 2025 (≈ 50.100203 NVST) would be worth
$1,391.78
+$391.78 (+39.2%) today · 1.39× · US Dollar
Based on a NVST entry price of $19.96 vs. today's $27.78.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $26.17 | $1,061.52 | +6.2% |
| 1 month ago | $26.35 | $1,054.27 | +5.4% |
| 3 months ago | $26.33 | $1,055.07 | +5.5% |
| 6 months ago | $23.47 | $1,183.64 | +18.4% |
| 1 year ago | $19.96 | $1,391.78 | +39.2% |
| All time (5.0y) ago | $43.83 | $633.81 | -36.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NVST forecast.
Our base-case forecast reaches $56.00 around 2031.
Implied market cap at $56.00: $9.11B
The multi-year forecast depicts a growing trajectory with rising averages and sizable upside, starting from 2026 and accelerating through 2050.
For 2026, the min, avg, and max are $21.69, $26.74, and $34.53 respectively, with ROI 0 and a Neutral sentiment.
From 2027 onward, the outlook strengthens: 2027 avg $31.40 with ROI 17.4 and Neutral sentiment; 2028 avg $33.91 (ROI 26.8) and Bullish; 2029 avg $39.22 (ROI 46.7) and Bullish; 2030 avg $43.83 (ROI 63.9) and Bullish; 2031 avg $51.79 (ROI 93.7) and Bullish. By 2032–2035, the forecast shows continued gains, with 2032 avg $62.71 (ROI 134.5), 2033 avg $64.90 (ROI 142.7), 2034 avg $67.42 (ROI 152.1), and 2035 avg $74.44 (ROI 178.4).
The long-range view extends to 2040 with avg $119.70 (ROI 347.6) and max $182.55, and to 2050 with avg $248.05 (ROI 827.6) and max $405.53, both described as Bullish. These figures illustrate a substantial upside potential over the coming decades, though they are estimates and not guaranteed.
Tap a question to reveal the answer.
The 2030 forecast shows min $34.25, avg $43.83, max $59.72 with ROI 63.9 and sentiment BULLISH.
The outlook improves from Neutral in 2026 and 2027 to Bullish in later years, with rising average prices and positive ROI in multiple years; 2026 shows avg $26.74 and ROI 0 with Neutral sentiment, while longer-horizon years show stronger upside.
2030 max is $59.72, which is just under 60; 2031 max is $71.69, so reaching $60 could occur by 2031 according to the forecast.
The thirty-day range is $23.98 to $29.82, with a support of $22.87 and a resistance of $27.63.
Current price is $26.74 and market cap is $4.35B.
Envista Holdings Corporation Community Discussion
0Share your Envista Holdings Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.